Argentina In-Vitro Diagnostics Market is predicted to reach USD 482 Million by 2030

According to the study by Next Move Strategy Consulting, the Argentina In-Vitro Diagnostics Market size is predicted to reach USD 482 million, at a CAGR of 4% by 2030.

Request a FREE Sample: https://www.nextmsc.com/argentina-in-vitro-diagnostics-market/request-sample

Argentina's focus on bolstering public healthcare infrastructure is significantly driving the growth of in-vitro diagnostics market.

The escalating prevalence of chronic diseases in the region is driving the Argentina in-vitro diagnostics market growth.

The promising players operating in the Argentina in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.